Why should aspirin be stopped five days before coronary artery bypass grafting (CABG) but continued for percutaneous coronary intervention (angioplasty)?

Why P2Y12 Inhibitors (Not Aspirin) Must Be Stopped Before CABG

P2Y12 inhibitors like clopidogrel (Axcer/Plavix) must be stopped 5 days before CABG because they dramatically increase surgical bleeding, blood transfusions, and reoperation rates, while aspirin can be safely continued because it reduces perioperative mortality and graft thrombosis with only modest bleeding increases that don't translate to worse clinical outcomes. 1, 2

The Critical Difference: Bleeding Risk vs. Benefit Profile

Why P2Y12 Inhibitors Must Be Stopped

For elective CABG, P2Y12 inhibitors create unacceptable bleeding risk:

• Clopidogrel and ticagrelor: Stop ≥5 days before surgery 1, 2, 3
• Prasugrel: Stop ≥7 days before surgery 1, 2
• Urgent CABG: Can proceed ≥24 hours after stopping, though bleeding risk remains elevated 1, 2

The evidence is clear: P2Y12 inhibitors used within 5 days of CABG increase major bleeding by 50%, transfusion requirements by 70%, and reoperation rates significantly 4. When CABG is performed <24 hours after stopping clopidogrel, the risk of life-threatening complications like pericardial tamponade increases substantially 3.

Why Aspirin Should Be Continued

Aspirin demonstrates a fundamentally different risk-benefit profile:

• Reduces operative mortality and morbidity 2, 3
• Improves saphenous vein graft patency 2
• Only modestly increases bleeding without increasing reoperation rates 5
• Should be given preoperatively (100-325 mg daily) 1, 2

The landmark ATACAS trial (2,100 patients) found that perioperative aspirin resulted in no difference in death, MI, stroke, or reoperation for bleeding compared to placebo 4, 5. A large cohort study of >8,000 patients showed aspirin within 5 days of CABG reduced overall mortality without increasing reoperation risk 4.

Why PCI (Angioplasty) Is Different

During PCI, both aspirin AND P2Y12 inhibitors are continued because:

1. No surgical field to bleed into - catheter-based procedure with minimal tissue trauma
2. Acute stent thrombosis risk - stopping antiplatelet therapy during/immediately after stent placement causes catastrophic thrombosis
3. Procedural anticoagulation already given - heparin/bivalirudin used regardless, so incremental bleeding risk is manageable
4. Access site bleeding is controllable - femoral/radial artery compression manages bleeding effectively

The guidelines explicitly state that in patients with NSTE-ACS undergoing early invasive strategy with PCI, dual antiplatelet therapy should be continued throughout the procedure 1, 6.

The Mechanistic Explanation

P2Y12 inhibitors cause irreversible platelet inhibition lasting 7-10 days:

• Clopidogrel/prasugrel/ticagrelor permanently block the P2Y12 receptor on platelets
• New platelets must be produced (10-14 days for complete turnover)
• Even 5 days allows ~50% platelet function recovery

Aspirin's effects are more manageable:

• Also irreversible, but affects different pathway (COX-1)
• Lower magnitude of bleeding increase
• Benefits in preventing graft thrombosis outweigh bleeding risk in CABG

Common Pitfalls to Avoid

Don't confuse urgent with elective CABG timing:

• Elective: Full 5-7 day washout period required
• Urgent: Can proceed at 24 hours if clinical situation demands, accepting higher bleeding risk 1, 2

Don't stop aspirin before CABG:

• Historical practice was to stop aspirin 7-10 days preoperatively
• Current evidence shows this increases mortality without reducing meaningful bleeding 2, 4

Don't use the same rules for CABG and PCI:

• CABG = open surgical field, stop P2Y12 inhibitors
• PCI = catheter-based, continue all antiplatelet therapy

For hybrid procedures (CABG + PCI):

• Perform CABG first when possible to avoid operating on dual antiplatelet therapy 3
• Verify graft patency before proceeding to PCI 3

Post-Operative Management

After CABG, restart antiplatelet therapy promptly:

• Aspirin within 6 hours postoperatively if not given preoperatively 2
• Continue aspirin indefinitely 2
• Consider resuming P2Y12 inhibitor within 24 hours post-CABG in appropriate patients 4

The key distinction is that CABG creates a large surgical field where uncontrolled bleeding can cause tamponade and death, while PCI is a percutaneous procedure where the thrombotic risk of stopping antiplatelet therapy far exceeds the manageable bleeding risk of continuing it.